Sirt2 inhibition suppressed the fibrogenic gene α-SMA and Fibronectin expression in TGF-β1 treated lung fibroblasts and primary lung fibroblasts derived from patients with IPF. The gene discussed is TGFB1; the disease is idiopathic pulmonary fibrosis.